FromAstraZeneca ([email protected])
Subject (90)Imfinzi granted Priority Review in the US for patients with muscle-invasive bladder cancer
Preheader (90)Imfinzi granted Priority Review in the US for patients with muscle-invasive bladder cancer
Arial
Text Analysis
Body Words194
Subject Words13
Body Emojis1
Subject Emojis
Media Analysis
Text Links8
Image Links4
Total Links12
Images7
Technical Metrics
Performance
HTML Size, Kb
Pixel Length, px708 px
X-Spam Score-3.1
Preheader OptimizedNo
Timing
Day of WeekFriday
TimeEvening
